Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)
Bangladesh
· Delayed Price · Currency is BDT 8.30
+0.10 (1.22%)
At close: Mar 9, 2026
Central Pharmaceuticals Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Market Capitalization | 994 | 1,246 | 2,168 | 1,486 | 1,569 | 1,581 | Upgrade
|
| Market Cap Growth | -31.97% | -42.54% | 45.97% | -5.34% | -0.76% | -0.75% | Upgrade
|
| Enterprise Value | 1,262 | 1,513 | 2,454 | 1,752 | 1,818 | 1,803 | Upgrade
|
| Last Close Price | 8.30 | 10.40 | 18.10 | 12.40 | 13.10 | 13.20 | Upgrade
|
| PS Ratio | 29.68 | 37.69 | 73.26 | 50.65 | 60.37 | 10.67 | Upgrade
|
| PB Ratio | 1.22 | 1.51 | 2.57 | 2.22 | 2.20 | 2.02 | Upgrade
|
| P/TBV Ratio | 1.22 | 1.51 | 2.57 | 2.22 | 2.20 | 2.02 | Upgrade
|
| P/FCF Ratio | - | - | 731.27 | - | - | - | Upgrade
|
| P/OCF Ratio | - | - | 731.27 | - | - | 880.40 | Upgrade
|
| EV/Sales Ratio | 37.65 | 45.77 | 82.90 | 59.75 | 69.92 | 12.17 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | - | - | 45.42 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | - | 264.59 | Upgrade
|
| EV/FCF Ratio | - | - | 827.53 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.33 | 0.33 | 0.32 | 0.40 | 0.38 | 0.32 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | - | 6.33 | Upgrade
|
| Debt / FCF Ratio | - | - | 90.64 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.33 | 0.33 | 0.32 | 0.40 | 0.37 | 0.32 | Upgrade
|
| Net Debt / EBITDA Ratio | -32.12 | -246.49 | -11.01 | -12.66 | -11.31 | 6.26 | Upgrade
|
| Net Debt / FCF Ratio | -1354.50 | -515.45 | 90.05 | -819.93 | -238.46 | -52.00 | Upgrade
|
| Asset Turnover | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.11 | Upgrade
|
| Inventory Turnover | 2.53 | 2.22 | 2.55 | 1.90 | 1.26 | 2.06 | Upgrade
|
| Quick Ratio | 0.20 | 0.20 | 0.23 | 0.25 | 0.25 | 0.26 | Upgrade
|
| Current Ratio | 1.09 | 1.10 | 1.14 | 1.18 | 1.25 | 1.37 | Upgrade
|
| Return on Equity (ROE) | -3.56% | -2.63% | -5.60% | -6.35% | -9.12% | -1.08% | Upgrade
|
| Return on Assets (ROA) | -1.30% | -0.99% | -1.74% | -2.32% | -2.49% | 0.31% | Upgrade
|
| Return on Invested Capital (ROIC) | -2.73% | -2.06% | -3.68% | -4.99% | -5.30% | 0.67% | Upgrade
|
| Return on Capital Employed (ROCE) | -2.80% | -2.10% | -3.40% | -5.10% | -5.40% | 0.60% | Upgrade
|
| Earnings Yield | -2.97% | -1.76% | -1.96% | -2.96% | -4.35% | -0.54% | Upgrade
|
| FCF Yield | - | -0.04% | 0.14% | -0.02% | -0.07% | -0.30% | Upgrade
|
| Buyback Yield / Dilution | 2.27% | - | - | - | - | - | Upgrade
|
| Total Shareholder Return | 2.27% | - | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.